Cargando…
Recent Progress in the Systemic Treatment of Advanced/Metastatic Cholangiocarcinoma
SIMPLE SUMMARY: The incidence of cholangiocarcinomas is rising. The prognosis of this heterogeneous group of tumors remains poor. Standard chemotherapy options are limited and frequently not effective. Recently, extensive molecular profiling identified key actionable drivers leading to successful bi...
Autores principales: | Fostea, Raluca Maria, Fontana, Elisa, Torga, Gonzalo, Arkenau, Hendrik-Tobias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565778/ https://www.ncbi.nlm.nih.gov/pubmed/32932925 http://dx.doi.org/10.3390/cancers12092599 |
Ejemplares similares
-
Novel Treatments for Metastatic Cutaneous Melanoma and the Management of Emergent Toxicities
por: Lemech, Charlotte, et al.
Publicado: (2012) -
Combination Therapies for the Treatment of Advanced Melanoma: A Review of Current Evidence
por: Voskoboynik, Mark, et al.
Publicado: (2014) -
Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities
por: Fontana, Elisa, et al.
Publicado: (2020) -
Recent Advances in Understanding Cholangiocarcinoma
por: Kennedy, Lindsey, et al.
Publicado: (2017) -
Recent advances in understanding cholangiocarcinoma
por: Uson Junior, Pedro Luiz Serrano, et al.
Publicado: (2020)